- Home
- CNK vs IMVT Comparison
CNK vs IMVT Comparison
Compare CNK & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNK
- IMVT
- Stock Information
- Founded
- CNK 1984
- IMVT N/A
- Country
- CNK United States
- IMVT United States
- Employees
- CNK 29200
- IMVT N/A
- Industry
- CNK Movies/Entertainment
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CNK Consumer Discretionary
- IMVT Health Care
- Exchange
- CNK Nasdaq
- IMVT Nasdaq
- Market Cap
- CNK 2.9B
- IMVT 3.6B
- IPO Year
- CNK 2007
- IMVT N/A
- Fundamental
- Price
- CNK $23.61
- IMVT $18.86
- Analyst Decision
- CNK Buy
- IMVT Strong Buy
- Analyst Count
- CNK 11
- IMVT 12
- Target Price
- CNK $31.45
- IMVT $46.11
- AVG Volume (30 Days)
- CNK 4.5M
- IMVT 1.0M
- Earning Date
- CNK 05-01-2025
- IMVT 02-06-2025
- Dividend Yield
- CNK 0.34%
- IMVT N/A
- EPS Growth
- CNK 54.03
- IMVT N/A
- EPS
- CNK 2.06
- IMVT N/A
- Revenue
- CNK $3,049,500,000.00
- IMVT N/A
- Revenue This Year
- CNK $10.02
- IMVT N/A
- Revenue Next Year
- CNK $7.03
- IMVT N/A
- P/E Ratio
- CNK $11.61
- IMVT N/A
- Revenue Growth
- CNK N/A
- IMVT N/A
- 52 Week Low
- CNK $16.32
- IMVT $17.65
- 52 Week High
- CNK $36.28
- IMVT $35.97
- Technical
- Relative Strength Index (RSI)
- CNK 29.64
- IMVT 40.91
- Support Level
- CNK $23.66
- IMVT $18.85
- Resistance Level
- CNK $24.61
- IMVT $20.70
- Average True Range (ATR)
- CNK 0.96
- IMVT 1.02
- MACD
- CNK -0.12
- IMVT 0.10
- Stochastic Oscillator
- CNK 23.79
- IMVT 36.66
About CNK Cinemark Holdings Inc Cinemark Holdings Inc.
Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).